首页 › 基金 › BERNZOTT CAPITAL ADVISORS › HALO
BERNZOTT CAPITAL ADVISORS 对 HALO 的持仓历史
HALOZYME THERAPEUTICS INC · 医疗保健
BERNZOTT CAPITAL ADVISORS 在 Q2 2025 的 13F 申报中披露持有 HALO(HALOZYME THERAPEUTICS INC)70,403 股,市值约 US$3.7M,约占其申报组合的 1.87%,在其申报持仓中市值排名第 30 位。 BERNZOTT CAPITAL ADVISORS 最近 8 个申报季度中有 7 个季度披露了 HALO 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR
BERNZOTT CAPITAL ADVISORS 对 HALO 的持仓演变
BERNZOTT CAPITAL ADVISORS 于 Q3 2023 首次披露 HALO 持仓:171,808 股(约 US$6.6M)。 该持仓在 Q2 2024 达到峰值 187,249 股,市值约 US$9.8M。 在 7 次申报中,BERNZOTT CAPITAL ADVISORS 2 次增持、3 次减持、0 次保持不变。 最近一期申报(Q2 2025)显示持股 70,403 股、市值约 US$3.7M,环比减持 -31,357 股。。 持仓曾出现大幅变动:Q4 2023 减持约 27% (随后一个季度股价上涨 10%)、Q1 2024 增持约 68% (随后一个季度股价上涨 29%)、Q2 2025 减持约 31% (随后一个季度股价上涨 41%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 171.81K | $6.56M | 新进 |
| Q4 2023 | 124.98K | $4.62M | 减持 |
| Q1 2024 | 209.80K | $8.53M | 增持 |
| Q2 2024 | 187.25K | $9.80M | 减持 |
| Q4 2024 | 93.98K | $4.49M | 新进 |
| Q1 2025 | 101.76K | $6.49M | 增持 |
| Q2 2025 | 70.40K | $3.66M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 HALO 与 13F 数据
HALO(HALOZYME THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 43 只申报持有 HALO,申报仓位最大的包括:CONGRESS ASSET MANAGEMENT CO (US$251.9M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$196.5M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 HALO 的基金
- CONGRESS ASSET MANAGEMENT CO 2.28M 股 · $251.89M · Q3 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.51M 股 · $196.54M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 2.40M 股 · $187.54M · Q2 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 1.94M 股 · $151.69M · Q2 2026
- WASATCH ADVISORS LP 1.05M 股 · $115.88M · Q3 2026
- Stephens Investment Management Group LLC 1.39M 股 · $109.02M · Q2 2026
- GW&K Investment Management, LLC 1.35M 股 · $105.97M · Q2 2026
- Boston Trust Walden Corp 1.08M 股 · $84.77M · Q2 2026
- LMR Partners LLP 45.00M 股 · $65.81M · Q2 2026
- Mizuho Markets Cayman LP 834.50K 股 · $65.32M · Q2 2026
更多关于 BERNZOTT CAPITAL ADVISORS
常见问题
How long has BERNZOTT CAPITAL ADVISORS held HALO?
BERNZOTT CAPITAL ADVISORS has disclosed HALO holdings in 7 of the last 8 reported quarters, going back to Q3 2023.
What is BERNZOTT CAPITAL ADVISORS's current position in HALO?
As of Q2 2025, BERNZOTT CAPITAL ADVISORS holds 70.40K shares of HALO (HALOZYME THERAPEUTICS INC), valued at $3.66M, representing 1.87% of its reported portfolio and ranking #30.
Has BERNZOTT CAPITAL ADVISORS been buying or selling HALO?
In the latest 13F filing (Q2 2025), BERNZOTT CAPITAL ADVISORS reduced its position in HALO. The position peaked in Q2 2024 at 187.25K shares.
Which other funds hold HALO?
Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.